| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.3 | 0.07 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.07 |